Underlying heart disease | n = 75 patients |
Rheumatic heart disease, n (%) | 31 (41.3%) |
Mitral valve disease, n (%) | 28 (37.3%) |
Aortic valve disease, n (%) | 17 (22.7%) |
Mixed valvular heart disease, n (%) | 14 (18.7%) |
Congenital heart disease, n (%) | 26 (34.7%) |
Post tetrology of fallot ICR1, n (%) | 7 (9.3%) |
Post ICR with RV to PA conduit, n (%) | 1 (1.3%) |
Post ICR with PPI2, n (%) | 1 (1.3%) |
Tetrology of fallot, n (%) | 1 (1.3%) |
Ventricular septal defect, n (%) | 4 (5.3%) |
Bicuspid aortic valve, n (%) | 4 (5.3%) |
Patent ductucs arteriosus, n (%) | 2 (2.7%) |
Subaortic membrane, n (%) | 2 (2.7%) |
RSOV3 with VSD, n (%) | 1 (1.3%) |
Post truncus arteriosus reapir, n (%) | 1 (1.3%) |
Post Patent ductucs arteriosus ligation, n (%) | 1 (1.3%) |
Tetrology of fallot with post BT4 shunt, n (%) | 1 (1.3%) |
Prosthetic valves endocarditis, n (%) | 7 (9.3%) |
Mitral valve prolapsed, n (%) | 5 (6.7%) |
Degenerative valve disease, n (%) | 2 (2.7%) |
No previous known heart disease, n (%) | 8 (10.7%) |